Mumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary, Relonchem Limited in UK, has received marketing authorization for Cetirizine Dihydrochloride 1 mg/ml Oral Solution from UK Medicines and Healthcare products Regulatory Agency (MHRA).

This approval adds to a series of UK MHRA authorizations Relonchem has secured throughout the year.

Earlier this week, Relonchem also received marketing nod for Mefenamic Acid Film-Coated Tablets in 250 mg and 500 mg strengths from UK Medicines and Healthcare products Regulatory Agency (MHRA).

Earlier this month, the company received approval for Exemestane 25mg film-coated tablets from UK MHRA.

In October, Relonchem obtained Marketing Authorization for Clonidine 100 microgram Tablets and Clonidine Hydrochloride 25 microgra

See Full Page